stockrowLantheus Holdings, Inc.
LNTH Healthcare Drug Manufacturers Specialty & Generic
Lantheus Holdings, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.5 billion, up 0.50% from fiscal 2024.
- Revenue
- +1.54%
- EPS
- −17.1%
- Free cash flow
- +7.71%
- Total debt
- +0.52%
Quarter to September 2026, against a year earlier
Follow LNTH
Alert me
Lantheus Holdings, Inc. (LNTH) Free cash flow
Lantheus Holdings, Inc.'s free cash flow for fiscal 2025 was $354.1M, down 26.7% from $482.9M in fiscal 2024. Over the twelve months to 30 September 2026 it was $409.5M. Over the past ten years it has ranged from $3.9M (fiscal 2020) to $482.9M (fiscal 2024); the current reading is higher than 82% of that period. Lantheus Holdings, Inc. ranks 8th of 84 Drug Manufacturers Specialty & Generic companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $354.1M | (26.68%) |
| FY2024 | $482.9M | 35.44% |
| FY2023 | $356.5M | 34.43% |
| FY2022 | $265.2M | 360.48% |
| FY2021 | $57.6M | 1,368.61% |
| FY2020 | $3.9M | (93.28%) |
| FY2019 | $58.3M | 38.66% |
| FY2018 | $42.1M | 9.34% |
| FY2017 | $38.5M | (27.21%) |
| FY2016 | $52.8M | 513.74% |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $102.0M | 13.47% |
| Jun 2026 | $89.9M | (29.18%) |
| Mar 2026 | $126.9M | 55.92% |
| Dec 2025 | $81.4M | (14.03%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| LNTH Lantheus Holdings, Inc. | $409.5M |
| ALKS Alkermes plc compare | $228.4M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $197.2M |
| LQDA Liquidia Corporation compare | $150.7M |
| RDY Dr. Reddy's Laboratories Ltd compare | $96.0M |
| HIMS Hims & Hers Health, Inc. compare | $83.0M |
| SUPN Indivior Pharmaceuticals Inc. compare | $31.0M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | −$60.5M |
| AMLX Amylyx Pharmaceuticals, Inc. compare | −$130.7M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on LNTH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement